Document is current

Any future updates will be listed below

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Crossref DOI link: https://doi.org/10.1186/s13613-023-01194-x

Published Online: 2023-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark